Indivior Appoints New Board Members as CFO Steps Down; Shares Decline

Indivior PLC shares fell by 4.5% following the announcement of changes to its Board of Directors and the resignation of the company's CFO. The company announced today the appointment of two new independent non-executive directors, Robert Schriesheim and Joe Ciaffoni, with expertise in corporate transformation and the specialty pharmaceutical sector. These new members will also serve on the Board's Nominating and Operational Committee. To comply with the general practices of publicly traded companies in the U.S., INDV's Chief Financial Officer (CFO) Ryan Preblick will be stepping down. The search for a successor for Board Chairman Graham Hetherington, who is set to leave on October 4, 2024, is ongoing. The company is also considering adding another non-executive board member to the Board. Additionally, INDV plans to adopt a standard U.S. compensation system for board members. Under the proposed system, a significant portion of the compensation for board members, including non-executive directors, will be paid in the form of INDV shares.